Cited by 57Cytokine Signaling Pathways and InteractionsRheumatoid Arthritis Research and TherapiesT-cell and B-cell Immunology

Interleukin-6.

Hirano, T., Kishimoto, T.·1990·Handbook of Experimental Pharmacology

Integrity signals

Registry

Crossref · 10.1007/978-3-642-49295-2_14

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IL-6 is a pleiotropic cytokine involved in immune responses, inflammation, hematopoiesis, bone metabolism, embryonic development and other fundamental processes.

    “IL-6, which was discovered in 1986 (27), is a pleiotropic cytokine involved not only in immune responses but also in inflammation, hematopoiesis, bone metabolism, embryonic development and other fundamental processes (1, 21, 28–32).”

    From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [29]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hirano, T., & Kishimoto, T.
Affiliations
National Cancer Institute (US)
Venue
Handbook of Experimental Pharmacology
Published
1990
Pages
633-665
ISSN
  • 0171-2004 (ISSN-L)
  • 1865-0325
OpenAlex
W4211115166
Cited by
57
References
110
Citations by year
2026: 1 · 2025: 1 · 2022: 2 · 2021: 1 · 2020: 1 · 2018: 1 · 2016: 1 · 2014: 1
FWCI
11.89
Type
book chapter
Language
en
Open access
closed
Locations
Handbook of experimental pharmacology (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
interleukin-6, cytokines, B cell stimulatory factor 2, interferon-beta 2, hepatocyte-stimulating factor, plasmacytoma, multiple myeloma, chronic inflammation, lymphoid malignancies, acute phase response, hematopoiesis, immune regulation, transgenic mice, immunoglobulin heavy chain enhancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review